We thank you for the opportunity to respond to the issues raised in the letter and to clarify aspects of our methodology in relation to these concerns. We thank the authors of the letter for their interest in our article and for taking the time to express their concerns.
The authors of the letter noted that there was no information about the medical status of patients with HIV, duration of the disease, and why levels of hsCRP are higher in the patient group. The patients were in active phases of infection.
The authors have cited the work of Cekirdekci et al. [1], which showed that HIV-infected patients receiving combination antiretroviral therapy had longer Tp-e interval and Tp-e/QTc ratio, which correlated positively with the duration of disease and the electrophysiological abnormalities, and negatively with CD4 count. In our article, we mentioned under Methodology that “None were taking any antiarrhythmic drugs and antiretroviral drugs that could affect the electrocardiographic measurements at the time of admission” [1]. Additionally, we stated that “We investigated the electrocardiographic features of HIV-infected patients before starting antiretroviral drug treatment” in the Discussion section. Because we selected the patients the first time they were diagnosed, the patients did not use any medication and there was no duration of the disease. Our results support those of Brouillette et al. [2] who reported that prolonged QTc in HIV patients was independent of drug therapy.
C-reactive protein (CRP) is a well-known acute phase protein that is produced predominantly by hepatocytes in light of several cytokines such as interleukin-6 and tumor necrosis factor-alpha [3]. Several studies have shown that levels of the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1β are increased in HIV patients [4, 5]. Moreover, Lau et al. [6] showed that higher CRP levels are associated with lower CD4 counts and higher HIV viral RNA load in HIV-infected individuals. In addition, some studies found significant associations between elevated CRP levels and faster progression to AIDS and high risk of mortality [7, 8, 9, 10]. As the evidence-based studies demonstrate the importance of CRP, we supported the fact that higher hsCRP attributed to show that disease severity and increased R-peak time had positive correlations in our study [10].
Conflict of Interest Statement
There is no funding for this research to declare. There is no conflict of interest.
References
- 1.Cekirdekci EI, Unal Evren E, Evren H, Bugan B. R-peak time: a novel marker of depolarization in patients with Human Immunodeficiency Virus. J Electrocardiol. 2019 Jul–Aug;55:133–7. doi: 10.1016/j.jelectrocard.2019.05.016. [DOI] [PubMed] [Google Scholar]
- 2.Brouillette J, Grandy SA, Jolicoeur P, Fiset C. Cardiac repolarization is prolonged in CD4C/HIV transgenic mice. J Mol Cell Cardiol. 2007;43((2)):159–67. doi: 10.1016/j.yjmcc.2007.05.007. [DOI] [PubMed] [Google Scholar]
- 3.Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39–48. doi: 10.1111/j.1749-6632.1982.tb22124.x. [DOI] [PubMed] [Google Scholar]
- 4.Monsuez JJ, Escaut L, Teicher E, Charniot JC, Vittecoq D. Cytokines in HIV-associated cardiomyopathy. Int J Cardiol. 2007;120((2)):150–7. doi: 10.1016/j.ijcard.2006.11.143. [DOI] [PubMed] [Google Scholar]
- 5.Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y. IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am J Pathol. 2004;164((4)):1253–62. doi: 10.1016/S0002-9440(10)63213-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, et al. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med. 2006;166((1)):64–70. doi: 10.1001/archinte.166.1.64. [DOI] [PubMed] [Google Scholar]
- 7.Vishwanath A, Quaiser S, Khan R. Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J Sex Transm Dis. 2016 Jul–Dec;37((2)):123–8. doi: 10.4103/2589-0557.192127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Melchior JC, Niyongabo T, Henzel D, Durack-Bown I, Henri SC, Boulier A. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition. 1999;15((11–12)):865–9. [PubMed] [Google Scholar]
- 9.Redd AD, Eaton KP, Kong X, Laeyendecker O, Lutalo T, Wawer MJ, et al. C-reactive protein levels increase during HIV-1 disease progression in Rakai, Uganda, despite the absence of microbial translocation. J Acquir Immune Defic Syndr. 2010;54((5)):556–9. doi: 10.1097/QAI.0b013e3181e0cdea. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr. 2003;32((2)):210–4. doi: 10.1097/00126334-200302010-00014. [DOI] [PubMed] [Google Scholar]